InvestSMART

Artrya Limited (ASX: AYA) - Announcements

Current share price for AYA : $4.550 0.44 (10.71%)+

ASX company news and announcements for Artrya Limited (AYA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Artrya Limited (AYA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Artrya Limited (AYA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Artrya Limited (AYA)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$738 Ceasing to be a substantial holder 3 Aug 2026 12:34PM $3.980 $4.530 risen by 13.82%
$738 June Quarterly Activities Report and Appendix 4C 29 Jul 2026 8:37AM $5.090 $4.530 fallen by 11%
$738 Northeast Georgia Health System goes live with Salix 23 Jul 2026 8:30AM $5.410 $4.530 fallen by 16.27%
$738 Notification of cessation of securities - AYA 15 Jul 2026 4:32PM $5.820 $4.530 fallen by 22.16%
$738 Change of Director's Interest Notice - B Ridgeway 10 Jul 2026 4:56PM $5.770 $4.530 fallen by 21.49%
$738 Notification of cessation of securities - AYA 10 Jul 2026 4:51PM $5.770 $4.530 fallen by 21.49%
$738 Notification regarding unquoted securities - AYA 7 Jul 2026 4:22PM $5.980 $4.530 fallen by 24.25%
$738 Becoming a substantial holder 30 Jun 2026 5:45PM $6.100 $4.530 fallen by 25.74%
$738 Application for quotation of securities - AYA 25 Jun 2026 5:57PM $5.280 $4.530 fallen by 14.20%
$738 Share Issue and Cleansing Notice 25 Jun 2026 5:53PM $5.280 $4.530 fallen by 14.20%
$738 Change of Director's Interest Notice - B Ridgeway 18 Jun 2026 5:53PM $4.640 $4.530 fallen by 2.37%
$738 Application for quotation of securities - AYA 18 Jun 2026 5:47PM $4.640 $4.530 fallen by 2.37%
$738 Issue of Shares and Cleansing Notice 18 Jun 2026 5:42PM $4.640 $4.530 fallen by 2.37%
$738 Change of Director Interests Notice 12 Jun 2026 9:58AM $4.700 $4.530 fallen by 3.62%
$738 Sale of Shares to Fund Options Exercise 12 Jun 2026 9:58AM $4.700 $4.530 fallen by 3.62%
$738 Application for quotation of securities - AYA 2 Jun 2026 5:16PM $4.680 $4.530 fallen by 3.21%
$738 Issue of Shares and Cleansing Notice 2 Jun 2026 5:13PM $4.680 $4.530 fallen by 3.21%
$738 Ceasing to be a substantial holder 19 May 2026 5:54PM $4.880 $4.530 fallen by 7.17%
$738 Artrya appoints Clayton Hatch as Chief Financial Officer 18 May 2026 8:20AM $5.050 $4.530 fallen by 10.30%
$738 March Quarterly Activities Report and Appendix 4C 30 Apr 2026 9:15AM $4.120 $4.530 risen by 9.95%
$738 Change of Director's Interest Notice - B Ridgeway 14 Apr 2026 4:07PM $3.900 $4.530 risen by 16.15%
$738 Application for quotation of securities - AYA 14 Apr 2026 4:03PM $3.900 $4.530 risen by 16.15%
$738 Issue of Shares and Cleansing Notice 14 Apr 2026 3:56PM $3.900 $4.530 risen by 16.15%
$738 Application for quotation of securities - AYA 8 Apr 2026 3:56PM $3.900 $4.530 risen by 16.15%
$738 Issue of Shares and Cleansing Notice 8 Apr 2026 3:51PM $3.900 $4.530 risen by 16.15%

1 - 25 of 504 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.